期刊文献+

干扰素治疗慢性乙型肝炎不良反应的临床观察及处理措施 被引量:9

Clinical observation and nursing on adverse reactions of interferon when treating chronic hepatitis B
下载PDF
导出
摘要 目的观察干扰素在治疗慢性乙型肝炎过程中的不良反应,探讨减轻不良反应的护理措施,提高对慢性乙型肝炎患者干扰素治疗的依从性,保证患者能足量足疗程使用干扰素。方法对2011年1月-2012年7月我院收治的78例慢性乙型肝炎患者在干扰素治疗过程中出现的不良反应进行观察,并采取有效的护理措施和护理干预。结果 78例患者中出现流感样综合征的50例,占64.1%;乏力32例,占40%;食欲不振、恶心25例,占32.5%;失眠15例,占19.23%;烦躁不安6例,占8%;脱发5例,占6.41%。给予护理措施干预后,患者均能足量足疗程完成干扰素的治疗。结论干扰素的不良反应是可预见和可处理的,通过恰当的护理干预,可以帮助患者顺利完成干扰素治疗的整个过程。 Objective To observe the adverse reactions of interferon in the treatment for chronic hepatitis B,discuss the nursing measures in order to reduce adverse reactions,improve the compliance of interferon treatment and ensure the patients had interferon treatment full dose and full process.Methods 78 cases of patients sufferring chronic hepatitis B with interferon treatment were collected from January,2011 to July,2012,to observe adverse reactions and to take effective nursing measures.Results Of the 78 patients sufferring chronic hepatitis B,64.1 percent of them had the influenza-like symptom,40 percent of them had fatigue,32.5 percent of them had no appetite and nausea,19.23 percent of them had ahypnosis,8 percent of them had fidgets,6.41 percent of them had lipsotrichia.The patients can had interferon treatment full dose and full process after the nursing management.Conclusion Adverse reactions of interferon can be predicted and treated.The patients could be treated by interferon successfully through appropriate nursing measures.
出处 《实用药物与临床》 CAS 2012年第12期840-841,共2页 Practical Pharmacy and Clinical Remedies
关键词 慢性乙型肝炎 干扰素 不良反应 护理 Chronic hepatitis B Interferon Adverse reactions Nursing
  • 相关文献

参考文献6

二级参考文献24

共引文献196

同被引文献51

  • 1Zhong-Ming Tan,Bei-Cheng Sun.Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence[J].World Journal of Gastroenterology,2013,19(47):8895-8901. 被引量:22
  • 2周炯,王荫华.六个常用的焦虑抑郁量表的相关因子分析[J].中华神经科杂志,2005,38(11):714-714. 被引量:131
  • 3Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 4Forns X,Garcia Retortillo M,Serrano T,et al.Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation[J].J Hepatol,2003,39(3):389-396 被引量:1
  • 5Polido-WT Jr,Lee KH,Tay KH,et al.Adult living donor liver transplantation in Singapore:the Asian centre for liver diseases and transplantation experience[J].Ann Acad Med Singapore,2007,36(8):623-630 被引量:1
  • 6RIDRUEJO E. Safety of direct -acting antivirals in the treat- ment of chronic hepatitis C[ J]. Expert Opin Drug Saf, 2014, 13(3) : 307 -319. 被引量:1
  • 7HASHIMOTO Y, KANTO H, ITOH M. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combina- tion therapy in a patient with chronic hepatitis C virus [ J ]. J Dermatol, 2007, 34(8): 577-582. 被引量:1
  • 8LI Z, ZHANG Y, AN J, et al. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C[ J ]. J Clin Virol, 2014, 60 (3) : 190 -195. 被引量:1
  • 9. MIQUILENA -COLINA ME, LOZANO -RODRiGUEZ T, GARCiA -POZO L, et al. Recombinant interferon -alpha2b improves immune response to hepatitis B vaccination in haemodialysis pa- tients, results of a randomised clinical trial [ J ]. Vaccine, 2009,27(41 ) : 5654 -5660. 被引量:1
  • 10UCHIDA M, HAMADA A, YAMASAKI M, et al. Assessment of adverse reactions and pharmacokinetics of ribavirin in combina- tion with interferon alpha -2b in patients with chronic hepatitis C [J]. Drug Metab Pharmacokinet, 2004, 19(6) : 438 -443. 被引量:1

引证文献9

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部